The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative Activities-Reference-Cited by-同舟云学术

The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative Activities

Published:1987-10-02 Issue:4823 Volume:238 Page:75-78
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Siegel Jay P.¹,Sharon Michael²,Smith Paula L.¹,Leonard Warren J.²

Affiliation:

1. Division of Virology, Office of Biologics Research and Review, Center for Drugs and Biologics, Food and Drug Administration, Bethesda, MD 20892.

2. Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference31 articles.

1. BICTHUY, L.T., CELL IMMUNOL 98: 396 (1986).

2. DOMZIG, W, INTERLEUKIN-2 DEPENDENCE OF HUMAN NATURAL-KILLER (NK) CELL-ACTIVITY, JOURNAL OF IMMUNOLOGY 130: 1970 (1983).

3. DUKOVICH, M, A 2ND HUMAN INTERLEUKIN-2 BINDING-PROTEIN THAT MAY BE A COMPONENT OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS, NATURE 327: 518 (1987).

4. ENGLEMAN, E.G., ACTIVATION OF HUMAN LYMPHOCYTE-T SUBSETS - HELPER AND SUPPRESSOR-CYTOTOXIC T-CELLS RECOGNIZE AND RESPOND TO DISTINCT HISTOCOMPATIBILITY ANTIGENS, JOURNAL OF IMMUNOLOGY 127: 2124 (1981).

5. GRAY, J.D., FUNCTIONAL-STUDIES ON THE PRECURSORS OF HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS, CELLULAR IMMUNOLOGY 96: 338 (1985).

Cited by 429 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells;Cellular and Molecular Life Sciences;2024-08-31

2. Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview;Pharmaceutics;2024-07-24

3. Enhanced Immunomodulatory Activity of Sargassum horneri Extract through T Cell Regulation in Immunosuppressed Mouse Model and Jurkat Cells;Journal of the Korean Society of Food Science and Nutrition;2024-04-30

4. Efficacy, safety and the lymphocyte subsets changes of low‐dose IL‐2 in patients with systemic lupus erythematosus: A systematic review and meta‐analysis;Immunity, Inflammation and Disease;2024-01

5. Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases;BioDrugs;2023-11-24